Diageo Plc -- 5.1/10 -- $73.32

AVOID / WATCHLIST

NYSE: DEO (ADR) | DGE.L (primary) | World largest premium spirits company with dominant positions in scotch, stout, Canadian whisky, and gin. Brands include Johnnie Walker, Guinness, Smirnoff, Don Julio, Crown Royal, and Tanqueray. Down 37% from 52-week highs near $117, trading at $73 with a 4.4% dividend yield and RSI of 32.1 approaching oversold. Revenue declining, margins compressing, EPS falling. CEO and CFO both replaced in the last 18 months. Strong contrarian sentiment (7/10) but weak financials (4) and management credibility (4) keep the composite below threshold.

FY2025 Net Sales

$20.2B

-0.1% YoY | H1 FY26 -4.0% YoY

Operating Margin (FY2025)

28.2%

-110bps YoY | H1 FY26 31.1% (+20bps)

Forward P/E

11.5x

vs 15.7x peer avg | 4.4% dividend yield

Composite Score

5.1 / 10

AVOID - Below 6 threshold

Quality gate results

Oligopoly / Dominant Position

YES

Over 30% share in scotch (~34%), stout/Guinness (~40%), Canadian whisky (~45-50%), and gin (~30-35%). These categories represent ~53% of revenue. Diageo is the price setter in premium spirits with unmatched portfolio breadth across 200+ brands. Near-impossible to replace within 12 months.

Positive and Growing FCF

YES

FY2025 FCF of $2.7B, up 5.3% YoY. H1 FY26 FCF $1.5B (typically H2-weighted). Targeting $3B annual from FY26. FCF is the one consistently positive financial metric despite top-line and margin pressure. Dividend well covered at 4.4% yield.

Management 3+ Year Track Record

CEO Debra Crew departed mid-2025 after ~2 years. CFO also replaced. New CEO Dave Lewis (ex-Tesco turnaround). Promise hit rate just 33% (4/12). Medium-term guidance formally withdrawn. $1.4B in exceptional charges. 3 C-suite changes in 18 months. Extreme leadership instability.

Gate result: One NO on management track record. Score normally but note the gap prominently. Management instability is the key risk -- three C-suite changes in 18 months, guidance withdrawn, and a 33% promise hit rate severely damage credibility. New CEO Dave Lewis is a turnaround specialist (Tesco) but is unproven at Diageo. Strategic review expected summer 2026.

Score breakdown

/ 10

Financial Trends Weight: 25%

Revenue flat-to-declining on reported basis: FY24 -0.1%, H1 FY26 -4.0% YoY. Operating profit declining 3-4% annually. EPS down -8.6% FY25 and -2.5% H1 FY26. Op margin compressed from 29.3% to 28.2% (-110bps). Leverage rose to 3.4x vs 2.5-3.0x target. FCF is the bright spot at $2.7B (+5.3% YoY). Accelerate program ($625M savings) provides credible forward inflection. Tariff disruption and US/China weakness are near-term drags.

/ 10

Thematic Exposure Weight: 25%

Oligopoly gate passed with over 30% share in 4 categories (~53% of revenue). World largest premium spirits company with unmatched portfolio breadth. Strong positions in tequila (+8-10% CAGR), Guinness (+5% CAGR, 8th consecutive half of double-digit growth), and India IMFL whisky (+8-10% CAGR). Capped below 7 because theme growth is only ~3-5% volume. Key categories in organic decline (scotch -4%, vodka -5%). GLP-1/moderation headwinds real.

/ 10

Management Quality Weight: 20%

Promise hit rate of 33% (4 of 12 tracked commitments). 5-7% organic NSV target missed and formally withdrawn. Op profit guidance missed repeatedly. Leverage above target and worsening. Dividend cut after progressive policy promise. 4 red flags: CEO/CFO churn (3 changes in 18 months), guidance withdrawn, $1.4B exceptional charges (Distill Ventures/Aviation impairments), leverage above target. New CEO Dave Lewis is a potential positive but unproven.

/ 10

Investor Sentiment Weight: 15%

Genuine management-Street divergence: management guides mid-single-digit EBIT growth, Street is skeptical. ~13 Buy / 9 Hold / 1 Sell on DGE.L with wide dispersion. Average target implies +45-50% upside. Not a crowded trade. RSI 32 near oversold. Stock near 52-week lows. CFO sold ~GBP 715K in March 2026 (mild negative). Low retail attention with washed-out GLP-1/dividend-cut narrative. Classic contrarian setup.

/ 10

Concerns, Catalysts & Risks Weight: 15%

Valuation discount is the primary positive: 11.5x forward P/E vs 15.7x peer average, 4.4% yield vs 2.4% peers. Key catalysts: new CEO strategic update (summer 2026), Accelerate $625M savings, Guinness momentum, potential China disposal. Key risks: tariff ~$200M pre-mitigation, China baijiu -56% H1 FY26, GLP-1 demand erosion 1-3% annually, leverage 3.4x above target. Score above 5 requires USMCA clarity and Accelerate proof.

Dimension	Score	Weight	Weighted
Financial Trends	4	25%	1.00
Thematic Exposure	6	25%	1.50
Management Quality	4	20%	0.80
Investor Sentiment	7	15%	1.05
Concerns, Catalysts & Risks	5	15%	0.75
Composite		100%	5.1

Company overview

Diageo is the world largest premium spirits company with a portfolio of over 200 brands spanning scotch (Johnnie Walker), beer (Guinness), tequila (Don Julio, Casamigos), vodka (Smirnoff, Ketel One), Canadian whisky (Crown Royal), rum (Captain Morgan), gin (Tanqueray), and liqueurs (Baileys). FY2025 net sales of $20.2 billion. The company operates globally: North America ~40% of sales, Europe ~20%, Asia Pacific ~15%, Africa ~10%, Latin America and Caribbean ~10%, and Travel Retail ~5%. NYSE ADR ticker DEO; primary listing DGE.L on the London Stock Exchange. Fiscal year ends June 30, with semi-annual reporting (H1 December, FY June).

The investment case has two competing narratives. The bull case centers on Diageo as a world-class spirits franchise trading at a multi-year low valuation (11.5x forward P/E vs 15.7x peers) with a new turnaround CEO (Dave Lewis, ex-Tesco). The contrarian setup is strong: RSI 32 near oversold, analyst targets imply +45-50% upside, and the 4.4% dividend yield is nearly double the peer average. The Accelerate program targets $625M in savings with ~50% in FY26. Guinness has delivered 8 consecutive halves of double-digit growth. Tequila and India remain high-growth vectors.

The bear case is that financial trends are deteriorating and management credibility is severely damaged. Revenue is declining, margins are compressing, EPS is falling, and leverage has risen to 3.4x (above the 2.5-3.0x target). The CEO and CFO were both replaced in 18 months. Management hit only 33% of tracked promises, withdrew medium-term guidance, cut the dividend, and took $1.4B in exceptional charges. Tariffs threaten ~$200M pre-mitigation. China baijiu volumes collapsed -56%. GLP-1 drugs represent a slow-moving 1-3% annual demand headwind. The valuation discount may be justified.

Price	$73.32	FY2025 Net Sales	$20.2B (-0.1% YoY)
Market Cap	$41.0B	Op Margin (FY25)	28.2% (-110bps YoY)
Forward P/E	11.5x	EPS Pre-Exceptional (FY25)	164.2c (-8.6% YoY)
Dividend Yield	4.42%	FCF (FY2025)	$2.7B (+5.3% YoY)
52-Week Range	$72.45 - $116.69	Net Debt / EBITDA	3.4x (target 2.5-3.0x)
RSI	32.14	Mgmt Promise Hit Rate	33% (4 of 12)

Summary thesis

DEO receives a composite score of 5.1/10, reflecting weak financial trends (4) and management credibility (4), partially offset by solid thematic positioning (6) in oligopoly categories and a strong contrarian sentiment signal (7). The score falls below the 6.0 threshold for a constructive view.

Bull case (~$100-110, +35-50%): New CEO Dave Lewis executes Accelerate savings ($625M, ~50% in FY26), translating to margin expansion and mid-single-digit organic op profit growth. Guinness momentum continues. Tequila and India drive premiumization. China disposed or stabilized. USMCA exemption secured for 46% of US sales. P/E re-rates from 11.5x toward 14-15x on improved execution visibility. 4.4% yield provides income floor near oversold levels.

Base case (~$80-90, +10-20%): Accelerate delivers partial savings. Organic growth remains low single digits. Margins stabilize but do not meaningfully expand. Leverage begins to decline but stays above 3.0x. Lewis strategic review provides clarity but no step-change. P/E holds at ~12-13x on FY27 estimates. Dividend maintained.

Bear case (~$55-60, -20-25%): Tariffs escalate beyond $200M with no USMCA relief. China disposal at distressed valuation. GLP-1 adoption accelerates demand erosion. US spirits market continues to weaken. Leverage remains elevated, forcing further dividend cuts. Lewis unable to reverse decline in key categories. P/E compresses to 9-10x on continued earnings misses.

Bottom line: Diageo is a world-class spirits franchise with genuine oligopoly positions in 4 categories, trading at a meaningful discount to peers. The contrarian setup is real -- deeply depressed stock, wide analyst-target upside, and near-oversold technicals. But the financial deterioration is broad-based, management credibility is severely damaged, and the risk profile is complex (tariffs, China, GLP-1, leverage). AVOID / Watchlist, and monitor for evidence that (1) Accelerate savings translate to margin expansion, (2) Lewis strategic review provides a credible path forward, and (3) USMCA exemptions are secured. FY2026 results (Aug 2026) and the Lewis strategic review (summer 2026) are the key decision points.

What to watch

Key catalysts and monitoring points:

FY2026 results (~Aug 2026): Full-year proof point for Accelerate savings and whether mid-single-digit organic op profit growth is achievable. FCF target of $3B. Margin trajectory is the key metric -- any expansion above 28.2% signals inflection.
Lewis strategic review (summer 2026): New CEO expected to lay out medium-term strategy. Watch for portfolio rationalization (China disposal?), RTD/mass-market pivot, capital allocation changes, and revised financial targets. Credibility of new guidance is critical given predecessor withdrawal.
USMCA tariff exemption: 46% of US sales depend on USMCA status. ~$200M pre-mitigation tariff exposure. Resolution would materially de-risk the near-term outlook. Monitor trade policy developments closely.
Guinness momentum: 8th consecutive half of double-digit growth. Guinness is 18% of revenue and the strongest brand in the portfolio. Any deceleration would remove a key pillar of the bull case.
China resolution: Baijiu volumes collapsed -56% in H1 FY26 (~5-7% of revenue). Potential disposal would be a catalyst -- removes an earnings drag and simplifies the portfolio. Watch for announcements in the Lewis strategic review.
Leverage trajectory: Net debt/EBITDA at 3.4x vs 2.5-3.0x target. Needs to come down to restore financial flexibility and dividend credibility. Accelerate savings and FCF growth are the path, but any further deterioration would be a red flag.
GLP-1 demand impact: Slow-moving 1-3% annual demand erosion. Monitor US spirits consumption data and Diageo US volume trends for early signal of acceleration.

For the full analysis, see the Financials, Thematics, and Management pages.

Data sourced from Daloopa (company_id: 3179) and DEO earnings transcripts (H1 FY2023 through FY2025).